经尿道前列腺机器人水刀切除术在治疗良性前列腺增生中的应用

doi:10.19558/j.cnki.10-1020/r.2020.01.001

摘要
图/表
参考文献(17)
相关文章 (15)

全文: PDF (1002 KB) RICH HTML
输出: BibTeX | EndNote (RIS)

摘要良性前列腺增生（BPH）是老年男性的常见疾病,经尿道前列腺电切术（TURP）,是治疗前列腺增生的“金标准”。在过去的几十年中,泌尿外科医生一直在努力寻找能够达到TURP有效性但安全性更高的新技术。美国加州PROCEPT BioRobotics公司结合了水刀、超声图像实时引导和机器人控制技术,发明了AquaBeam“前列腺水刀机器人手术系统”,该系统利用高速无菌盐水射流作为切割介质,自动完成前列腺切割和移除。2015年,采用AquaBeam进行的“经尿道前列腺机器人水刀切除术”(Aquablation)的安全性得以初步验证,该系统是唯一通过美国FDA、欧盟CE的泌尿外科专用手术机器人,目前已纳入最新版美国泌尿外科协会（AUA）和欧洲泌尿外科协会（EAU）前列腺增生症治疗指南。现介绍这一技术的特色,临床应用及相关研究。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	史涛坪
	张旭

关键词 ：经尿道前列腺手术, 机器人, 水刀, 良性前列腺增生

Abstract：Benign prostatic hyperplasia (BPH) is a common disease in older males. Transurethral resection of the prostate (TURP) is regarded as the “gold standard” for the treatment of BPH. Over the last decade, there have been efforts to identify new technologies that can replicate the effectiveness of TURP but with an improved safety profile. PROCEPT BioRobotics (California, United States) combined novel minimally invasive water ablation therapy, image guidance and robotics to invent AquaBeam “Prostate Waterjet Robotic Surgical System”, which uses high-speed sterile saline jet as the cutting medium to automatically complete prostate cutting and removal. Since 2015, the safety of the Transurethral Robotic Waterjet Resection” (Aquablation) using AquaBeam was preliminarily verified. The system is the unique urology-specific surgical robot that has been certificated by the USA FDA and Euro CE, and has been included in the latest version of Guidelines for the treatment of BPH in the American Urological Association (AUA) and European Association of Urology (EAU). In this article, we will focus on the characteristics, clinical applications, and related research of this technology.

Key words： transurethral resection of the prostate aquablation robotic waterjet benign prostatic hyperplasia

收稿日期: 2020-02-22

ZTFLH:

R697.32

通讯作者: 张旭,xzhang@foxmail.com

引用本文:

史涛坪, 张旭. 经尿道前列腺机器人水刀切除术在治疗良性前列腺增生中的应用[J]. 微创泌尿外科杂志, 2020, 9(1): 1-5.
SHI Taoping, ZHANG Xu. Application of aquablation for the surgical treatment of benign prostatic hyperplasia. JOURNAL OF MINIMALLY INVASIVE UROLOGY, 2020, 9(1): 1-5.

链接本文:

http://journal20.magtechjournal.com/Jwk_zgmnwk/CN/abstract/abstract1557.shtml 或 http://journal20.magtechjournal.com/Jwk_zgmnwk/CN/Y2020/V9/I1/1

[1] CORNU JN, AHYAI S, BACHMANN A, et al.A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction: An Update. Eur Urol, 2015,67(6):1066-1096.
[2] PAYTON S.BPH: Lasers equal TURP in head-to-head study. Nat Rev Urol, 2014,11(1):6.
[3] BASTING RF, CORVIN S, ANTWERPEN C, et al.Use of water jet resection in renal surgery: early clinical experiences. Eur Urol, 2000,38(1):104-107.
[4] JEPPSSON B.Liver dissection in hepatic surgery: ultrasound vs water jet vs suction knife. Hepatology, 1990,11(3):509-510.
[5] TAKEUCHI Y, UEDO N, ISHIHARA R, et al.Efficacy of an endo-knife with a water-jet function (Flushknife) for endoscopic submucosal dissection of superficial colorectal neoplasms. Am J Gastroenterol, 2010,105(2):314-322.
[6] CHENG YY, SUN Y, LI J, et al.Transurethral endoscopic submucosal en bloc dissection for nonmuscle invasive bladder cancer: A comparison study of HybridKnife-assisted versus conventional dissection technique. J Cancer Res Ther, 2018,14(7):1606-1612.
[7] FABER K, DE ABREU AL, RAMOS P, et al.Image-guided robot-assisted prostate ablation using water jet-hydrodissection: initial study of a novel technology for benign prostatic hyperplasia. J Endourol, 2015,29(1):63-69.
[8] GILLING P, ANDERSON P, TAN A.Aquablation of the Prostate for Symptomatic Benign Prostatic Hyperplasia: 1-Year Results. J Urol, 2017,197(6):1565-1572.
[9] GILLING P, BARBER N, BIDAIR M, et al.WATER: A Double-Blind, Randomized, Controlled Trial of Aquablation((R)) vs Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia. J Urol, 2018,199(5):1252-1261.
[10] GILLING P, REUTHER R, KAHOKEHR A, et al.Aquablation - image-guided robot-assisted waterjet ablation of the prostate: initial clinical experience. BJU Int, 2016,117(6):923-929.
[11] FOSTER HE, BARRY MJ, DAHM P, et al.Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline. J Urol, 2018,200(3):612-619.
[12] GRAVAS S, GACCI M, GRATZKE C, et al.Tikkinen Guidelines Associates: M. Karavitakis, I. Kyriazis, S. Malde, V. Sakalis, R. Umbach. EAU Guidelines on Management of Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO). European Association of Urology Suppl, 2019:40-41.
[13] DESAI M, BIDAIR M, BHOJANI N, et al.WATER II (80-150 mL) procedural outcomes. BJU Int, 2019,123(1):106-112.
[14] DESAI M, BIDAIR M, ZORN KC, et al.Aquablation for benign prostatic hyperplasia in large prostates (80-150 mL):6-month results from the WATER II trial. BJU Int, 2019,124(2):321-328.
[15] GILLING P, BARBER N, BIDAIR M, et al.Two-Year Outcomes After Aquablation Compared to TURP: Efficacy and Ejaculatory Improvements Sustained. Adv Ther, 2019,36(6):1326-1336.
[16] GILLING P, BARBER N, BIDAIR M, et al.Three-year outcomes after Aquablation therapy compared to TURP: results from a blinded randomized trial. Can J Urol, 2020,27(1):10072-10079.
[17] GILLING PJ, BARBER N, BIDAIR M, et al.Randomized Controlled Trial of Aquablation versus Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia: One-year Outcomes. Urology, 2019,125:169-173.